Growth Metrics

Scholar Rock Holding (SRRK) Debt to Equity (2017 - 2026)

Scholar Rock Holding's quarterly Debt to Equity came in at $0.71 in Q1 2026, up 347.29% year-on-year from $0.16 in Q1 2025, and up 75.38% quarter-over-quarter from $0.41 in Q4 2025.

Scholar Rock Holding has reported Debt to Equity for 10 years, with the latest figure at $0.71 in Q1 2026.

  • For the quarter ending Q1 2026, Debt to Equity rose 347.29% year-over-year to $0.71; the trailing twelve-month figure through Mar 2026 stood at $0.71 (up 347.29% YoY), and the FY2025 full-year result was $0.41, up 198.58% from the prior year.
  • Debt to Equity for Q1 2026 stood at $0.71, up from $0.41 in the prior quarter.
  • The five-year high for Debt to Equity was $0.71 in Q1 2026, with the low at $0.14 in Q4 2024.
  • Average Debt to Equity over 5 years is $0.3, with a median of $0.25 recorded in 2023.
  • Year-over-year, Debt to Equity sank 43.09% in 2025 and soared 347.29% in 2026.
  • Tracing SRRK's Debt to Equity over 5 years: stood at $0.19 in 2022, then advanced by 16.18% to $0.22 in 2023, then plunged by 38.75% to $0.14 in 2024, then surged by 198.58% to $0.41 in 2025, then jumped by 75.38% to $0.71 in 2026.
  • The last three Debt to Equity figures came in at $0.71 (Q1 2026), $0.41 (Q4 2025), and $0.41 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt/Equity (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn -
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 0.06
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn -
10 Scholar Rock Holding 500.61 Mn 20.67 Mn - 0.71

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 0.71
Dec 31, 2025 0.41
Sep 30, 2025 0.41
Jun 30, 2025 0.21
Mar 31, 2025 0.16
Dec 31, 2024 0.14
Sep 30, 2024 0.63
Jun 30, 2024 0.37
Mar 31, 2024 0.27
Dec 31, 2023 0.22
Sep 30, 2023 0.30
Jun 30, 2023 0.25
Mar 31, 2023 0.22
Dec 31, 2022 0.19
Sep 30, 2022 0.17
Jun 30, 2022 0.15
Mar 31, 2022 0.29
Dec 31, 2021 0.29
Sep 30, 2021 0.13
Jun 30, 2021 0.11
Mar 31, 2021 0.10
Dec 31, 2020 0.09
Sep 30, 2020 0.00
Jun 30, 2020 0.00
Mar 31, 2020 0.00
Dec 31, 2019 0.00
Sep 30, 2019 0.00
Jun 30, 2019 0.00
Mar 31, 2019 0.00
Dec 31, 2018 0.00
Sep 30, 2018 0.01
Jun 30, 2018 0.01
Dec 31, 2017 -0.02